Syncom Formulations (India) Ltd. benchmarking: Performance to industry peers

Financial

	Syncom Formulations	Beta Drugs	Sakar Healthcare
Operational Metrics
Financials
5 yr Average ROE	9.79 %	22.74 %	8.14 %
5yr average Equity Multiplier	1.41	1.82	1.76
5yr Average Asset Turnover Ratio	0.81	1.03	0.45
5yr Avg Net Profit Margin	8.78 %	12.23 %	10.03 %
Price to Book	2.87	5.42	3.94
P/E	15.76	25.18	47.33
5yr Avg Cash Conversion Cycle	61.57 Days	7.75 Days	18.72 Days
Inventory Days	27.32 Days	46.07 Days	51.79 Days
Days Receivable	82.75 Days	91.57 Days	53.06 Days
Days Payable	79.41 Days	119.03 Days	115.64 Days
5yr Average Interest Coverage Ratio	31.44	14.42	4.85
5yr Avg ROCE	13.63 %	27.84 %	8.92 %
5yr Avg Operating Profit Margin	9.97 %	21.76 %	24.94 %
5 yr average Debt to Equity	0.19	0.29	0.49
5yr CAGR Net Profit	36.24 %	29.34 %	10.38 %
5yr Average Return on Assets	7.11 %	12.69 %	4.54 %
Shareholdings
Promoter Holding	50.57 %	64.9 %	52.86 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-1.81 %	-9.24 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Syncom Formulations	Beta Drugs	Sakar Healthcare
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 99.22 Rental Income 0.78 Trading of Commodities 0 Manufacturing of Oncology medicines 0 Loan Licensing 0 Export 0 CDMO 0 Pharmaceuticals 0	Product Wise Break-Up Export 0 Rental Income 0 Loan Licensing 0 Pharmaceutical 0 Trading of Commodities 0 CDMO 0 Pharmaceuticals 0 Oncology 100.0	Product Wise Break-Up Export 73.0 Rental Income 0 Loan Licensing 5.0 Pharmaceutical 0 Trading of Commodities 0 CDMO 22.0 Pharmaceuticals 0 Manufacturing of Oncology medicines 0
Location Wise Break-Up	Location Wise Break-Up International 84.5 Domestic 15.5	Location Wise Break-Up India 71.03 International 0 Others 28.97	Location Wise Break-Up Domestic 44.52 International 55.48
Drug Delivery Break-Up	Drug Delivery Break-Up Tablets 79.76 Injectables 6.08 Capsules 2.14 Liquids 1.82 Ointment 1.0 Dry Powder 0.49 Others 8.71	-	-
Capex	Capex Formulations 100.0 Trading of Commodities 0 Renting of Property 0	-	-
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceutical Drugs & Formulations 95.57 Renting of Property 4.43 Trading of Commodities 0	-	-
Raw Material Break-Up	Raw Material Break-Up Tapentadol Hydrochloride 53.16 Packing Material 14.34 Paracetamol 3.0 CEFTRIAXONE SODIUM 0.78 Ibuprofen 0.74 Others 27.98	-	-
Asset Break-Up	Asset Break-Up Formulations 89.07 Renting of Property 10.38 Trading of Commodities 0.55	-	-